Arbutus Biopharma Corp (ABUS)

3.18 -0.01 (-0.31%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Arbutus Biopharma Cash and Short Term Investments (Quarterly): 127.79M for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Biomarin Pharmaceutical Inc 930.44M
Amicus Therapeutics Inc 249.76M
Ionis Pharmaceuticals Inc 2.483B
GlycoMimetics Inc 14.39M
FibroGen Inc 131.00M